SECOND AMENDMENT TO THE LICENSE AND COLLABORATION AGREEMENTLicense and Collaboration Agreement • August 4th, 2005 • Tercica Inc • Pharmaceutical preparations
This SECOND AMENDMENT TO THE LICENSE AND COLLABORATION AGREEMENT (this “Second Amendment”) is made effective as of the 25th day of November, 2003 by and between Tercica, Inc., a Delaware corporation having an office located at 651 Gateway Boulevard, Suite 950, South San Francisco, California 94080 (formerly, Tercica Medica, Inc., “TM”) and Genentech, Inc., a Delaware corporation having an office at 1 DNA Way, South San Francisco, California 94080 (“GNE”). TM and GNE are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
SEPARATION AGREEMENT AND RELEASE RECITALSSeparation Agreement and Release • August 4th, 2005 • Tercica Inc • Pharmaceutical preparations • California
This Separation Agreement and Release (“Agreement”) is made by and between Thomas H. Silberg (“Employee”) and Tercica, Inc. (“Company”) (jointly referred to as the “Parties”):
